Amalgamated Bank
- SEC CIK
- 0000919192
- Latest filing
- Jul 23, 2026
ACRS holding history
Aclaris Therapeutics, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −2,883−100.0% | Sold out | Holders |
| Q4 2025 | 2,883 | $9.00K | <0.1% | −217−7.0% | Reduced | Holders |
| Q3 2025 | 3,100 | $6.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,100 | $4.00K | <0.1% | +3,100 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −2,307−100.0% | Sold out | Holders |
| Q1 2024 | 2,307 | $3.00K | <0.1% | −7,491−76.5% | Reduced | Holders |
| Q4 2023 | 9,798 | $10.0K | <0.1% | −686−6.5% | Reduced | Holders |
| Q3 2023 | 10,484 | $72.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,484 | $109.0K | <0.1% | +1,386+15.2% | Added | Holders |
| Q1 2023 | 9,098 | $74.0K | <0.1% | −1,355−13.0% | Reduced | Holders |
| Q4 2022 | 10,453 | $165.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,453 | $165.0K | <0.1% | +1,001+10.6% | Added | Holders |
| Q2 2022 | 9,452 | $132.0K | <0.1% | +1,146+13.8% | Added | Holders |
| Q1 2022 | 8,306 | $143.0K | <0.1% | +8,306 | New | Holders |